US Patent 7309710 Crystals
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+409 characters)
Article
Patent abstract
Obtaining the crystal of 4,6-dimethyl-4′-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]nicotinanilide having excellent activity of inhibiting Ca2+ release-activated Ca2+ channel and suppressing IL-2 production to find that the compound includes the presence of two types of polymorphic crystals and that any of the crystals is preferable as a raw material for producing pharmaceutical compositions.
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07309710 Crystals US Patent 7309710 Crystals
Infobox
Patent Number
0730971000
Patent Number
730971000
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073097100
Date of Patent
December 18, 2007
0Patent Application Number
105257090
Date Filed
August 26, 2003
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073097100
Date of Patent
December 18, 2007
0Patent Application Number
105257090
Date Filed
August 26, 2003
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07309710 Crystals
Infobox
Is a
Patent jurisdiction
Patent number
07309710
Date of patent
December 18, 2007
Patent application number
10525709
Date Filed
August 26, 2003
Patent primary examiner
Find more entities like US Patent 7309710 Crystals
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
